Audio

Russell Rosenberg, PhD

At SLEEP 2018, Dr. Rosenberg describes phase I trials that assessed patients' driving performance, ability to be awakened, and postural stability after taking the investigational sleepwake regulation drug lemborexant, compared with active and placebo comparators.


 

Limelight Video

Next Article: